Quantcast

Latest Mitral regurgitation Stories

2014-05-12 23:06:30

Revolutionizing developments in biological tissue vales will drive the European transcatheter heart valve implantation market to over $1.7 Billion by 2020, Reports iData Research Vancouver, BC (PRWEB) May 12, 2014 According to a new report on the European Market for Cardiac Surgery Devices by iData Research (http://www.idataresearch.com), the leading global authority in medical device and pharmaceutical market research, the total European Cardiac Surgery Devices market is projected to...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...

2014-04-09 16:26:11

ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendyne's novel Transcatheter Mitral Valve Implant to treat...

2014-02-19 12:28:22

Sets Stage for Expanded Adoption Of CARILLON® Mitral Contour System® KIRKLAND, Wash., Feb. 19, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced that the Company's CARILLON(® )Mitral Contour System(® )has received German Neue Untersuchungs und Behandlungsmethoden (NUB) Status 1 approval across 120 leading hospitals in Germany, a decision from German regulators that may positively influence reimbursement from insurance companies for the costs of CARILLON...

2014-02-18 12:30:32

- Harpoon Has Raised More Than $300,000 in Competitive Grants and Award Funding in Less Than a Year - BALTIMORE, Feb. 18, 2014 /PRNewswire/ -- University of Maryland (UM) Ventures and Harpoon Medical, Inc. announced today that Harpoon Medical has obtained exclusive rights to a portfolio of technologies for cardiac valve repair from the University of Maryland, Baltimore (UMB). The licensed technology was developed in the Division of Cardiac Surgery at The University of Maryland School...

2013-11-19 23:02:53

New Findings by Research Team, Including Researchers from Icahn School of Medicine at Mount Sinai, Showing Mitral Valve Replacement May Be More Effective Than Mitral Valve Repair Reported at AHA Scientific Sessions 2013 and in New England Journal of Medicine New York, NY (PRWEB) November 19, 2013 The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'